Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults

Hormone Research

Volumn 51, Issue 2, 1999, Pages 78-84

  Kim, Kyung Rae ^a   Nam, Su Youn ^a,b   Song, Young Duk ^a   Lim, Sung Kil ^a   Lee, Hyun Chul ^a   Huh, Kap Bum ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Growth hormone; Obesity; Visceral fat

Indexed keywords

FATTY ACID; GROWTH HORMONE; INSULIN; NITROGEN;

ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INSULIN RELEASE; LEAN BODY WEIGHT; LIPOLYSIS; MALE; NITROGEN BALANCE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BLOOD UREA NITROGEN; BODY COMPOSITION; COMBINED MODALITY THERAPY; DIET, REDUCING; DOUBLE-BLIND METHOD; FATTY ACIDS, NONESTERIFIED; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; KOREA; MALE; OBESITY; WEIGHT LOSS;

EID: 0033052163     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023319     Document Type: Article

References (27)

1. William T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA: Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 1984;311:1403-1407.
2. Ferini-Strambi L, Franceschi M, Cattaneo AG, Smirne S, Calori G, Caviezel F: Sleep-related growth hormone secretion in human obesity: Effect of dietary treatment. Neuroendocrinology 1991;54:412-415.
3. Abate N: Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care 1996;9:292-294.
4. Forbes GB: Weight loss during fasting: Implication for the obese. Am J Clin Nutr 1970;23: 1212-1217.
5. Byrd-Bredbenner C: Computer nutrient analysis software packages: Consideration for selection. Nutr Today 1988;23:13-21.
6. Fabiny DL, Ertingshausen G: Automated reaction-rate method for determination of serum creatinine with centrifichem. Clin Chem 1971; 17:696-700.
7. Durnin VJGA, Womersley J: Body fat assessed from body density and its estimation from skinfold thickness: Measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
8. Ashwell M, Cole TJ, Dixon AK: Obesity: New insight into the anthropometric classification of fat distribution shown by computed tomography. Br Med J 1985;290:1692-1694.
9. Rosenbaum M, Gertner JM, Leibel RL: Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab 1989;69:1274-1281.
10. Jørgensen JOL, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;i:1221-1225.
11. Slomon F, Cuneo RC, Hesp R, Sonksen PH: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321: 1797-1803.
12. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Brikenhager JC, Lambert SW: The effect of growth hormone administration in growth deficient adults on bone, protein, carbohydrate and lipid homeostasis as well as body composition. Clin Endocrinol 1992;37:79-87.
13. Clemmons DR, Snyder DK, Williams R, Underwood LE: Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J Clin Endocrinol Metab 1987;64:878-883.
14. Snyder DK, Clemmons DR, Underwood LE: Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects on anabolism, lipolysis, and body composition. J Clin Endocrinol Metab 1988;67:54-61.
15. Snyder DK, Underwood LE, Clemmons DR: Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. Am J Clin Nutr 1990;52:431-437.
16. Skaggs SR, Crist DM: Exogenous human growth hormone reduces body fat in obese women. Horm Res 1991;35:19-24.
17. Snyder DK, Underwood LE, Clemmons DR: Presistent lipolytic effect of exogenous growth hormone during caloric restriction. Am J Med 1995;98:129-134.
18. Richelsen B, Pedersen SB, Borglum JD, Moller-Pedersen T, Jorgensen J, Jorgensen JO: Growth hormone treatment of obese women for 5 weeks: Effect on body composition and adipose tissue LPL activity. Am J Physiol 1994;266:E211-E216.
19. Johansson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L, Bengtsson BA: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism and reduces diastolic blood pressure. J Clin Endocrinol 1997;82:727-734.
20. Tagliaferri M, Scacchi M, Pincelli, AI, Berselli ME, Silvestri P, Montesano A, Ortolani S, Dubini A, Cavagnini F: Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. Int J Obes 1998;22:836-841.
21. Cuneo RC, Salomon F, Wilmshurst P, Byrne C, Wiles CM, Hesp R, Sonksen PH: Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: Stimulation of the renin-aldosterone system. Clin Sci 1991; 81:587-592.
22. Segal KR, Burastero S, Chun A, Coronel P, Pierson RN, Wang J: Estimation of intracellular and total body water by multiple frequency bioelectrical impedence measurement. Am J Clin Nutr 1991;54:26-29.
23. Rizza RA, Mandarino LJ, Gerich JE: Effects of growth hormone on insulin action in man. Diabetes 1982;31:663-669.
24. Randle PJ, Garland PB, Hales CN: The glucose-fatty acid cycle: Its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1963;i:785-789.
25. Snyder DK, Clemmons DR, Underwood LE: Dietary carbohydrate content determines responsiveness to growth hormone in energy-restricted humans. J Clin Endocrinol Metab 1989;69:745-752.
26. Lee EJ, Lee EJ, Nam SY, Kim KR, Lee HC, Cho JH, Nam MS, Song YD, Lim SK, Huh KB: Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subject. J Clin Endocrinol Metab 1995;80:2495-2498.
27. Nam SY, Lee EJ, Kim KR, Lee HC, Nam MS, Cho JH, Huh KB: Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity. Metabolism 1996;45:594-597.